Left ventricular remodeling and 1-year clinical follow-up of the REOPEN-AMI trial.
暂无分享,去创建一个
[1] E. Romagnoli,et al. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitropruss , 2013, JACC. Cardiovascular interventions.
[2] F. Burzotta,et al. Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.
[3] G. Parodi,et al. Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.
[4] K. Jacobson,et al. Cardioprotective effects of adenosine A1 and A 3 receptor activation during hypoxia in isolated rat cardiac myocytes , 2004, Molecular and Cellular Biochemistry.
[5] A. Neskovic,et al. Left Ventricular Remodeling After Primary Coronary Angioplasty , 2002 .
[6] A. Neskovic,et al. Left Ventricular Remodeling After Primary Coronary Angioplasty: Patterns of Left Ventricular Dilation and Long-Term Prognostic Implications , 2002, Circulation.